Actinobacillus pleuropneumoniae is a pathogenic bacterium responsible for a highly contagious and often fatal form of bronchopneumonia in swine. Survival from a natural infection generally results in immunity from further infection by all 12 common serotypes, suggesting the presence of common protective antigens. We have identified one of the antigenic membrane proteins from A. pleuropneumoniae serotype 5, and cloned the gene which encodes it. This gene is found in all 12 serotypes, and encodes a protein with a predicted molecular mass of 30 kDa. Sequence analysis revealed that this antigen has a typical signal sequence characteristic of lipoproteins, and is likely to be secreted and inserted into the periplasmic side of the inner membrane. The gene shows high homology to the surface antigen CjaA of Campylobacter jejuni and to solute binding proteins of the ABC transporter family. The probable role of this protein in substrate binding and transport was supported by the presence of an upstream gene with significant homology to ATP binding proteins of the same family. In Escherichia coli, the cloned gene produced a protein which reacted strongly with convalescent sera from swine infected with A. pleuropneumoniae serotype 5, and weakly with sera from swine infected with serotype 1A or from swine vaccinated with a killed bacterin of serotype 1A or 5. It thus appears that this antigen displays some crossreactivity between serotypes, and may be less exposed in bacterins than in live cells. This protein, designated ApaA, may have an important role in nutrient acquisition and in the pathogenesis of infections caused by A. pleuropneumoniae. ß
Introduction
Pork producers around the world are well aware of the threat infectious diseases pose to their herds.
One pathogen in particular, the Gram-negative, pleomorphic bacterium Actinobacillus pleuropneumoniae, can cause devastating epidemics with high mortality and economic loss [1, 2] . This pathogen is a swine specialist and causes a rapidly developing and highly contagious form of bronchopneumonia with characteristic hemorrhagic lesions accompanied by ¢brin deposition [1] . The infection is passed from pig to pig through nasal secretions, and in an acute infection, death can occur in less than 24 h after initial contact. The bacterium can also cause a chronic infection which has no serious symptoms but is still contagious, making detection and eradication of this pathogen di¤cult [2] .
A. pleuropneumoniae produces a polysaccharide capsule which is highly antigenic, and capsule variability among di¡erent strains has been used for strain identi¢cation by serotyping [3] . More than 12 serotypes have been identi¢ed, of which serotypes 1, 5 and 7 are the most common in the USA [2^4] . Survival of a natural infection with any one virulent serotype will generally provide protective immunity from infection by any other serotype [5, 6] . This cross-protective immunity has not yet been achieved from commercially produced vaccines. Instead vaccines (e.g. killed whole cell bacterins) provide moderate serotype speci¢c immunity, leaving the animals open to infection from A. pleuropneumoniae strains of serotypes not included in the vaccine [2, 7] . These bacterins stimulate antibody production mainly against capsular polysaccharides, while natural infection raises antibody to capsule, lipopolysaccharide, and a wide array of exported and membrane associated proteins [7^9] . A novel vaccine which used outer membrane preparations was successful in eliciting signi¢cant cross-protective immunity against A. pleuropneumoniae serotypes 1A and 5 [9] .
One of the goals of our laboratory is to identify antigens which are involved in cross-protective immunity. These antigens are predicted to be a good target for vaccine development because they are expressed during a natural infection and may provide a function essential to pathogenesis. To facilitate the isolation of these antigens, a library of genomic DNA from A. pleuropneumoniae serotype 5 was constructed and individual clones were screened with convalescent sera from a pig infected with A. pleuropneumoniae serotype 5. In this paper, we describe the cloning and sequence analysis of a highly immunoreactive protein, and discuss its role in A. pleuropneumoniae and its potential utility in vaccine development.
Materials and methods

Strains and growth conditions
Escherichia coli DH5K [10] was used for propagation of plasmid vector pUC18 and recombinant clones. E. coli strains were grown on LB medium supplemented with ampicillin (100 Wg ml 31 ) for plasmid selection. The A. pleuropneumoniae reference strains used in this study are listed in Table 1 . These strains were grown on brain heart infusion broth or agar (Difco Laboratories) supplemented with V-factor (NAD) at 10 Wg ml 31 . These strains were grown at 37³C with a 5% CO 2 atmosphere when grown on plates.
DNA manipulations
Genomic DNA was puri¢ed from A. pleuropneumoniae strains by standard methods [10] . Plasmid DNA was isolated using the QIAprep-spin plasmid puri¢cation kit (Qiagen). Restriction enzymes, calf intestinal phosphatase, and DNA ligase were purchased from Boehringer Mannheim Biochemicals and used according to the manufacturer's instructions. DNA fragments used for subcloning or for use as probes were puri¢ed from agarose gels by excising the bands and isolating the DNA with Qiaex beads (Qiagen).
Plasmid library construction and screening
Genomic DNA from A. pleuropneumoniae 178 was digested with EcoRI, fragments were ligated into the alkaline phosphatase treated EcoRI site of pUC19, and the ligation was transformed into competent E. coli DH5K cells using standard methods [10] . Individual transformants were transferred to nitrocellulose membranes and screened by immunoblot for the presence of A. pleuropneumoniae antigens. The primary antiserum was convalescent serum from a pig infected with A. pleuropneumoniae 178, diluted 1:500 in TBST bu¡er (10 mM Tris-HCl pH = 8.0, 150 mM NaCl, 0.05% Tween 20) . Colonies producing antigens that reacted with the primary antiserum were detected with Staphylococcus aureus protein A conjugated with horseradish peroxidase (HRP) and 4-chloronaphthol colorimetric HRP substrate, as described by Cruz et al. [11] .
Southern blotting
Genomic DNA from A. pleuropneumoniae strains was digested to completion with EcoRI, and separated on a 0.7% agarose gel. DNA fragments were transferred to a nytran ¢lter by the method of Southern [12] . The ¢lter was probed with the insert from pTF15 (Fig. 1A) , which was labeled with digoxigenin using the DNA labeling and detection kit of Boehringer Mannheim Biochemicals. This ¢lter was also probed with a PCR generated digoxigenin labeled probe containing only the apaA gene. The primers used to make this probe were 5P-GAGTTCTAT-GAAACTAAGC-3P, and 5P-AACTCAAATGCT-TATTGCG-3P. Hybridization was carried out in 50% formamide with 5USSC at 42³C. High stringency washes were performed in 0.1USSC with 0.1% SDS at 68³C. Hybridizing bands were detected using alkaline phosphatase tagged anti-digoxigenin and the CDP-star chemiluminescent substrate from Boehringer Mannheim.
DNA sequencing and analysis
DNA sequencing was performed by the method of Sanger et al. [13] with the Sequenase 2.0 sequencing kit from United States Biochemicals or by automated sequencing performed at the DNA Sequencing Facility at Michigan State University. The sequencing primers used included the universal forward and reverse primers for pUC sequencing, as well as custom internal oligonucleotide primers designed from previously obtained sequence data. Database searches were performed using the BLAST algorithm and GenBank database available at the National Center for Biotechnological Information web server (http://www.ncbi.nlm.nih.gov/BLAST/). DNA alignments and motif identi¢cation were performed using the GAP and MOTIF programs of the Genetics Computer Group DNA analysis software [14] . The complete sequence of the pTF15 insert has been submitted to GenBank and assigned the accession number AF109148.
Production of antisera
Convalescent phase sera were collected at 6 weeks post infection from pigs experimentally infected with either A. pleuropneumoniae serotype 1A or 5 [8] . Serum samples were collected prior to infection as negative controls. Sera from pigs vaccinated with either serotype 1A or 5 formalinized whole cell bacterins were collected 2 weeks after the ¢nal of three vaccinations given at 2-week intervals.
SDS-PAGE and Western blotting
Whole cell extracts of recombinant E. coli clones and of A. pleuropneumoniae strain 178 were prepared by growing the bacteria overnight in broth cultures, collecting the cells by centrifugation, and boiling them in 1/2 volume of SDS loading bu¡er for 5 min. Proteins were analyzed by discontinuous SDS-PAGE on 12.5% polyacrylamide gels, as described by Laemmli [15] . Gels were either stained with Coomassie blue, or electrophoretically transferred to nitrocellulose membranes for immunoblot analysis as described by Towbin et al. [16] . After transfer, blots were blocked with 5% skim milk in TBST. The blots were washed and incubated overnight with primary antibody diluted in TBST with 1% bovine serum albumin and 0.05% sodium azide. Immunoreactive bands were detected with HRP conjugated S. aureus protein A as described above.
Results
Cloning and expression of an A. pleuropneumoniae antigen gene
A plasmid library of A. pleuropneumoniae 178 genomic DNA was constructed in the plasmid vector pUC18, and transformed into E. coli. Transformants were screened by immunoblot with convalescent serum from a pig infected with A. pleuropneumoniae 178, and immunoreactive colonies were identi¢ed. Whole cell lysates of immunoreactive transformants were analyzed by SDS-PAGE, and a colony was selected which produced a highly immunoreactive protein antigen with an apparent molecular mass of 28 kDa (Fig. 1B) .
The plasmid isolated from this transformant, designated pTF15, contained a 2.2-kb insert (Fig. 1A) . Restriction enzyme mapping identi¢ed a single SphI site within the insert of pTF15. Deletion derivatives were constructed and analyzed by Western blot for production of the 28-kDa antigen (Fig. 1B) . Cells containing pTF15 produced a unique protein which migrated at approximately 28 kDa which was not produced by cells containing deletions of pTF15. This indicated that the SphI site must have disrupted the gene encoding the 28-kDa protein. No other unique proteins were observed in extracts from cells containing pTF15 or its subclones.
Presence of the gene in all 12 serotypes of A. pleuropneumoniae
Plasmid pTF15 was isolated from a library of A. pleuropneumoniae serotype 5 DNA. To determine the ubiquity of this gene in A. pleuropneumoniae serotypes, a Southern blot was performed with the insert of pTF15 used as a probe, and genomic DNA from 12 A. pleuropneumoniae serotypes used as the target. The genomic DNA was digested with EcoRI, separated on an agarose gel, and blotted onto a nylon membrane. When this blot was probed with pTF15, all 12 serotypes were found to contain genomic DNA fragments which hybridized at high stringency (Fig. 2) . Serotype 5 displayed the expected 2.2-kb fragment, which was also present in serotypes 1 and 7. Serotypes 2, 4, 6, 8, and 12 all contained this antigen gene on an EcoRI fragment of approximately 11 kb, while in serotypes 3, 9, 10 and 11 the gene hybridized to a fragment of approximately 8 kb. Only one hybridizing fragment was observed in each lane, indicating that none of the serotypes had an internal EcoRI site in this region, and that there was no evidence of duplication of this gene in A. pleuropneumoniae.
Sequence analysis
The complete nucleotide sequence of the insert from pTF15 was determined (Fig. 3) . When this sequence was analyzed, one large, intact open reading frame was found, with two partial open reading frames £anking it (Fig. 1A) . These were initially designated orfs 1^3. The predicted amino acid sequences of each of the three open reading frames were independently used to search protein sequence databases for the presence of previously sequenced homologous genes.
The truncated Orf1 displayed high sequence similarity with the GlnQ proteins from Helicobacter pylori (69%) [17] and Bacillus subtilis (61%) [18] . GlnQ is an ATP binding protein involved in the uptake of glutamine from the environment. Three of the four signature motifs commonly found in the ATP binding subunits of ABC transporters (the helical domain, the linker peptide and Walker box B) [19, 20] were found within Orf1 (Fig. 3) . The fourth motif, Walker box A, is predicted to occur in the 5P region of orf1 not contained on pTF15. Fig. 4 . Alignment of the predicted amino acid sequences of A. pleuropneumoniae ApaA, C. jejuni CjaA, H. pylori GlnH and B. stearothermophilus GlnH. The arrow indicates the lipoprotein signal sequence cleavage site. Conserved amino acids among the four protein sequences are boxed. The amino acids comprising the signature sequence of family 3 solute binding proteins are indicated with an asterisk, while additional residues which were highly conserved in this family are marked with a plus. Orf2 was 834 bp and encoded a protein with a predicted molecular mass of 29 970 Da. Orf2 was preceded by a consensus ribosome binding site 5 bp upstream of the ATG start codon. An SphI restriction site was identi¢ed close to the 5P end of orf2. Thus orf2 would be disrupted in the subclones pBM1, pSP1, and pSP2 (Fig. 1A) . Since these deletions correlated with the loss of production of the 28-kDa antigen, orf2 was designated apaA (A. pleuropneumoniae antigen A). In order to con¢rm that apaA is present in 12 serotypes of A. pleuropneumoniae, a PCR generated probe containing only the apaA gene was used to screen the Southern blot in Fig. 2 . Hybridizing bands of identical size to those seen with the larger probe were revealed using this truncated probe, con¢rming that apaA is present in all 12 serotypes.
The N-terminus of ApaA contains a 22-amino acid hydrophobic leader sequence with a predicted cleavage site in front of the cysteine residue at position 23. This arrangement is characteristic of bacterial lipoproteins [21] . The presence of an aspartate residue at position 24 indicates that after acylation of the cysteine residue, ApaA would be localized to the periplasmic surface of the cytoplasmic membrane rather than to the outer membrane [21] . The remainder of the ApaA protein had no signi¢cant stretches of hydrophobic amino acids which could serve as membrane spanning domains. Thus ApaA is predicted to be a periplasmic lipoprotein anchored to the inner membrane.
When ApaA was compared to the protein sequence databases, it displayed high sequence similarity to the CjaA protein from C. jejuni (60.4% similarity) as well as to the GlnH proteins from H. pylori (62.2%) and Bacillus stearothermophilus (36.8%). CjaA is an antigenic protein associated with pathogenesis in C. jejuni [22, 23] . GlnH is a solute binding protein and functions with GlnQ in the transport of glutamine [24] . These four sequences were aligned to look for regions of high homology (Fig. 4) . All four proteins had characteristic lipoprotein signal sequences with a cysteine residue at the cleavage site, and thus they are likely to undergo similar posttranslational modi¢cations. Amino acids previously identi¢ed as being conserved in members of solute binding protein family 3A, which includes GlnH and other polar amino acid binding proteins [25] , were highly conserved in ApaA. In addition, long stretches of sequence identity were found between ApaA, CjaA and GlnH from H. pylori which were not conserved in GlnH from B. stearothermophilus, indicating a closer relationship in form and potentially in function among these three proteins.
Orf3 is likely to initiate with a GTG start codon, and encodes a protein with high sequence similarity to the amino terminus of KpsC protein from E. coli [26] . KpsC is a 75-kDa protein involved in the export of capsular polysaccharides.
Between orf1 and apaA several A-T rich regions were found which could serve as transcriptional promoters for apaA in E. coli. No sequences resembling transcriptional terminators were found in this area, indicating that in the A. pleuropneumoniae chromosome orf1 and apaA may constitute part of an operon. A 16-bp inverted repeat structure which could serve as a transcriptional terminator was found between apaA and orf3, and this was followed by a potential sigma-70 type promoter. This suggests that orf3 is transcribed independently of orf1 and apaA.
Crossreactivity of the antigen with serotypes 1 and 5
To determine whether the ApaA antigen was immunologically crossreactive, and whether it was present and antigenic in whole cell bacterins used for vaccination, Western blots were performed using sera from pigs infected with or vaccinated against A. pleuropneumoniae serotypes 1A and 5. Whole cell extract from E. coli containing pTF15 was electrophoresed on a polyacrylamide gel and blotted onto a nitrocellulose ¢lter. This ¢lter was probed in strips with ¢ve di¡erent sera (Fig. 5) . No proteins were detected with serum from an uninfected pig. The ApaA protein reacted strongly with convalescent serum from a pig infected with serotype 5, and weakly with serum from a pig vaccinated with a serotype 5 bacterin. The ApaA protein reacted weakly with sera from serotype 1A infected or vaccinated pigs.
Conclusions
In this paper we report the cloning, sequencing and immunological characterization of a surface antigen from the porcine pathogen A. pleuropneumoniae. This cloned gene, apaA, produces an immunoreactive 28-kDa protein when expressed in E. coli. The estimated size of this protein as predicted from SDS-PAGE gels correlates very well with the size of the mature protein predicted from DNA sequencing. Analysis of the DNA sequence also suggests that the ApaA protein is likely to be a lipoprotein that is secreted into the periplasm, acylated, and inserted into the periplasmic side of the inner membrane. Sequence homology predicts that once secreted, ApaA would function as part of an ABC transport system involved in the acquisition of a polar amino acid such as glutamine from the environment.
The ApaA protein produced in E. coli did not appear to correspond in size to a major immunoreactive protein from A. pleuropneumoniae whole cell extracts (Fig. 1B) . This may indicate that expression of apaA is low in A. pleuropneumoniae, or its expression may be repressed when grown on laboratory media. Alternatively, the ApaA protein may be subject to varying posttranslational modi¢cations in these two species resulting in altered migration on SDS-PAGE gels.
ABC transport systems are ubiquitous in nature, and are characterized by the presence of a cytoplasmic protein with a conserved ATP binding cassette which provides energy for the system. These systems have evolved and diverged to allow for the transport of a wide variety of substrates [27] . In bacteria, the transport systems for glutamine and other polar amino acids display signi¢cant similarity to each other. In addition to an ATP binding protein, these systems also possess one or two membrane spanning proteins which form the permease, and a secreted protein which captures the solute to be transported from the environment. The genes for this system are often found in operon structures. In A. pleuropneumoniae, the apaA gene appears to be part of an operon with an upstream gene which shows homology to GlnQ. This arrangement is also found in B. stearothermophilus, B. subtilis, and H. pylori [17, 24, 18] . In E. coli, GlnQ is separated from GlnH by the glutamine permease gene glnP. In H. pylori, two copies of glnP were identi¢ed upstream of glnQ, while in B. subtilis the permease gene is found downstream of glnH. A permease gene was not found downstream of apaA, so if a permease gene is part of this operon in A. pleuropneumoniae, it would have to be upstream of orf1, similar to the organization found in H. pylori.
The apaA gene was cloned in opposite orientation to the lacZ promoter present on the cloning vector pUC18. This indicates that as well as its probable location within an operon, apaA can also be expressed from an alternate promoter located between orf1 and apaA. This region has several stretches rich in As and Ts which could potentially serve as promoters in E. coli. Whether such potential promoters would also function in A. pleuropneumoniae is not known.
ApaA is most closely related to GlnH of H. pylori, and to the C. jejuni antigen CjaA. H. pylori GlnH was sequenced as part of a genome sequencing project, and its identity was inferred by homology to GlnH in B. stearothermophilus and other species [17] . C. jejuni cjaA was identi¢ed as a gene encoding an antigenic membrane protein. This protein was recognized as having homology to members of the family three ABC transporter solute binding proteins such as GlnH; however, cjaA was not found to be part of an operon with other ABC transport genes [22] . In di¡erent strains of C. jejuni, the CjaA protein has been associated with virulence [23] , though the role of CjaA has not yet been elucidated. A. pleuropneumoniae ApaA was identi¢ed, like CjaA, as an antigenic protein; however, unlike cjaA, apaA does appear to be part of a larger ABC transport system operon. Further research will be required to determine the exact nature and function of both of these proteins.
The ApaA protein reacts strongly with convalescent serum from an A. pleuropneumoniae serotype 5 infected pig. It must therefore be expressed and exposed to the pig's immune system at some point during infection. As sequence information predicts that ApaA should be wholly contained within the periplasm, it seems unlikely that it would be exposed on the surface of intact cells during infection. It is possible, however, that cell death and lysis occur as a natural part of infection, exposing ApaA and other proteins to the host's immune cells. It is also possible that the degree to which this occurs could vary among serotypes. This could explain why serum from a pig infected with serotype 1A displayed a much weaker reaction to ApaA than serum from a pig infected with serotype 5, in that the pig infected with serotype 1A may have had less ApaA exposure than the serotype 5 infected pig. This would similarly explain the weak reaction of sera from pigs vaccinated with formalinized whole cell bacterins. These preparations are unlikely to contain many lysed cells, and thus very little ApaA protein would be exposed to the host.
Bacterial pathogenesis can be seen as a balance between the bacterium's ability to acquire the nutrients it needs for its survival and growth, and the host's ability to limit the bacterium's growth by sequestering these nutrients and then eliminating the bacterium through an immune response. In the case of A. pleuropneumoniae infecting the lungs of pigs, various factors in£uence this balance. Upon initial infection, the bacterium is favored and is able to colonize, damage tissues, acquire nutrients, divide and cause illness before the host is able to mount an immune response. However, subsequent infection favors the host whose immunological memory keeps the bacterium in check long enough for a fresh immune response to eliminate it. Vaccination serves to establish immunological memory su¤cient to prevent illness. In order to be e¡ective, vaccines must provide the host with enough targets to respond to so that it is su¤ciently primed to block the growth of virulent organisms. While a subunit vaccine consisting of ApaA is unlikely to serve this purpose, construction of an apaA mutant may produce an attenuated strain which would be incapable of causing disease, but would stimulate an immune response equivalent to that produced from a natural infection. Our laboratory is currently involved in the construction of attenuated mutants to serve as vaccine strains. It is believed that this strategy will lead to an e¡ective and cross-protective vaccine against this devastating disease.
